AKT1 and non-small cell lung carcinoma: Kaempferol may regulate EGFR/PI3K/AKT and IGF1R/PI3K/AKT signaling pathways by targeting EGFR, IGF1R, PIK3R1 and Akt, and then play a role in the treatment of non-small cell lung cancer.